Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cmv-specific t-cells (1 trial)
aav-rpgr (1 trial)
raav.hcnga3 (1 trial)
hydrocortisone (solu-cortef) (3 trials)
testosterone (delatestryl) (1 trial)
Adrenal Insufficiency (Phase 1)
Color Vision Defects (Phase 2)
Cytomegalovirus Infections (Phase 3)
Hypogonadism (Phase 1)
Retinitis (Phase 2)
Retinitis Pigmentosa (Phase 2)
Trials (7 total)
Trial APIs (5 total)